Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription 04.03.2024 2 Am J Med 2 BMJ 1 Drug Saf 1 Epidemiol Infect 2 J Virol 4 Lancet 2 MMWR Morb Mortal Wkly Rep 4 N Engl J Med 25 PLoS One 3 Proc Natl Acad Sci U S A 7 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. WONG RJ, Yang Z, Ostacher M, Zhang W, et al
   Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States.
   Am J Med. 2024;137:236-239.
   PubMed         Abstract available
   
   
2. REDELMEIER DA, Wang J, Drover SSM
   COVID Vaccine Hesitancy and Long-Term Traffic Risks.
   Am J Med. 2024;137:227-235.
   PubMed         Abstract available
   
   

   
   BMJ

3. BENTLEY-EDWARDS KL, Adisa O, Ruff KE, McClure ES, et al
   Race, racism, and covid-19 in the US: lessons not learnt.
   BMJ. 2024;384:e076106.
   PubMed        
   
   
4. WISE J
   Covid-19: Two rare vaccine side effects detected in large global study.
   BMJ. 2024;384:q488.
   PubMed        
   
   

   
   Drug Saf

5. MORO PL, Ennulat C, Brown H, Woody G, et al
   Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
   Drug Saf. 2024 Feb 27. doi: 10.1007/s40264-024-01406.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

6. SCHWARTZ RA, Suskind RM
   Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
   Epidemiol Infect. 2023;152:e34.
   PubMed         Abstract available
   
   

   
   J Virol

7. ZHANG M, Liu M, Chen H, Qiu T, et al
   PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A.
   J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944.
   PubMed         Abstract available
   
   
8. HAN J, Chang W, Fang J, Hou X, et al
   The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by viral NS1 protein-mediated activation of the TGF-beta pathway.
   J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512.
   PubMed         Abstract available
   
   

   
   Lancet

9. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
   The INSPIRE study: RSV infection during infancy - Authors' reply.
   Lancet. 2024;403:729-730.
   PubMed        
   
   
10. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    PubMed        
    
    
11. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    PubMed        
    
    
12. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

13. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    PubMed         Abstract available
    
    
14. ZHU S, Quint J, Leon TM, Sun M, et al
    Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:175-179.
    PubMed         Abstract available
    
    

    
    N Engl J Med

15. ELLINGJORD-DALE M, Brunvoll SH, Soraas A
    Prospective Memory Assessment before and after Covid-19.
    N Engl J Med. 2024;390:863-865.
    PubMed        
    
    
16. AL-ALY Z, Rosen CJ
    Long Covid and Impaired Cognition - More Evidence and More Work to Do.
    N Engl J Med. 2024;390:858-860.
    PubMed        
    
    
17. HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:806-818.
    PubMed         Abstract available
    
    
18. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    PubMed        
    
    

    
    PLoS One

19. BRAGA JU
    Clinical predictors of severe forms of influenza A(H1N1)pdm09 in adults and children during the 2009 epidemic in Brazil.
    PLoS One. 2024;19:e0291843.
    PubMed         Abstract available
    
    
20. PETERSON AD, Kibbey MM, Farris SG
    Linguistic analysis of health anxiety during the COVID-19 pandemic.
    PLoS One. 2024;19:e0299462.
    PubMed         Abstract available
    
    
21. UPPALA R, Sitthikarnkha P, Faksri K, Kosalaraksa P, et al
    Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era.
    PLoS One. 2024;19:e0297991.
    PubMed         Abstract available
    
    
22. SHIMUL SN, Hussain M, Faisel AJ, Hamid SA, et al
    Impact of alternative Non-Pharmaceutical Interventions strategies for controlling COVID-19 outbreak in Bangladesh: A modeling study.
    PLoS One. 2024;19:e0293863.
    PubMed         Abstract available
    
    
23. CICEK M, Greenfield G, Nicholls D, Majeed A, et al
    Predictors of unplanned emergency hospital admissions among patients aged 65+ with multimorbidity and depression in Northwest London during and after the Covid-19 lockdown in England.
    PLoS One. 2024;19:e0294639.
    PubMed         Abstract available
    
    
24. DIAS E, Diniz AMA, Souto GR, Guerra HL, et al
    Predicting COVID-19 cases in Belo Horizonte-Brazil taking into account mobility and vaccination issues.
    PLoS One. 2024;19:e0269515.
    PubMed         Abstract available
    
    
25. KURIHARA I, Sugawara H
    A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study.
    PLoS One. 2024;19:e0290937.
    PubMed         Abstract available
    
    
26. BASHIR IM, Al-Waleedi AA, Al-Shaibani SM, Rajamanar M, et al
    Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.
    PLoS One. 2024;19:e0298603.
    PubMed         Abstract available
    
    
27. SAVAGE MJ, Magistro D, Hennis PJ, Donaldson J, et al
    Determining factors of physical activity and sedentary behaviour in university students during the COVID-19 pandemic: A longitudinal study.
    PLoS One. 2024;19:e0298134.
    PubMed         Abstract available
    
    
28. TAM MW, Davis VH, Ahluwalia M, Lee RS, et al
    Impact of COVID-19 on access to and delivery of sexual and reproductive healthcare services in countries with universal healthcare systems: A systematic review.
    PLoS One. 2024;19:e0294744.
    PubMed         Abstract available
    
    
29. BAHARI NI, Sutan R, Abdullah Mahdy Z
    The determinants of maternal perception of antenatal care services during the COVID-19 pandemic critical phase: A systematic review.
    PLoS One. 2024;19:e0297563.
    PubMed         Abstract available
    
    
30. MEHRIZI R, Golestani A, Malekpour MR, Karami H, et al
    Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors.
    PLoS One. 2024;19:e0298604.
    PubMed         Abstract available
    
    
31. WU S, Li Y, Baral S, Mishra S, et al
    Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada.
    PLoS One. 2024;19:e0299304.
    PubMed         Abstract available
    
    
32. MARKOSE SM, Soyyigit S
    EU27 regional trade networks for medical products in fight against Covid-19 pandemic: Quantifying vulnerability and self sufficiency in critical inputs.
    PLoS One. 2024;19:e0297748.
    PubMed         Abstract available
    
    
33. TOMAZINI BM, Tramujas L, Medrado FA Junior, Gomes SPDC, et al
    Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial.
    PLoS One. 2024;19:e0299197.
    PubMed         Abstract available
    
    
34. NAGPAL S, Kumar R, Noronha RF, Kumar S, et al
    Seasonal variations in social contact patterns in a rural population in north India: Implications for pandemic control.
    PLoS One. 2024;19:e0296483.
    PubMed         Abstract available
    
    
35. SENTHINATHAN A, Cimino S, Jaglal SB, Craven BC, et al
    The impact of the COVID-19 virus and pandemic on healthcare utilization, access, delivery, experiences, and outcomes in the spinal cord injuries/dysfunction population: A scoping review study.
    PLoS One. 2024;19:e0297384.
    PubMed         Abstract available
    
    
36. LEON-HERRERA S, Samper-Pardo M, Olivan-Blazquez B, Sanchez-Recio R, et al
    Loss of socioemotional and occupational roles in individuals with Long COVID according to sociodemographic and clinical factors: Secondary data from a randomized clinical trial.
    PLoS One. 2024;19:e0296041.
    PubMed         Abstract available
    
    
37. TEKLEYOHANNES BA, Yifru YM, Nasir BB
    The impact of COVID-19 on treatment follow-up and medication adherence among patients with epilepsy at a referral hospital in Ethiopia.
    PLoS One. 2024;19:e0299065.
    PubMed         Abstract available
    
    
38. LEE J, Wilson J, Oosterhoff B, Shook NJ, et al
    Self-quarantining, social distancing, and mental health during the COVID-19 pandemic: A multi wave, longitudinal investigation.
    PLoS One. 2024;19:e0298461.
    PubMed         Abstract available
    
    
39. LECONA OA, Arroyo-Valerio AG, Bueno-Hernandez N, Carrillo-Ruiz JD, et al
    Risk factors contributing to infection with SARS-CoV-2 are modulated by sex.
    PLoS One. 2024;19:e0297901.
    PubMed         Abstract available
    
    
40. KUSI AMPONSAH A, Boateng EA, Armah J, Dompim JK, et al
    The psychosocial experiences of pregnant women in the early stages of the COVID-19 pandemic: A retrospective qualitative study.
    PLoS One. 2024;19:e0299219.
    PubMed         Abstract available
    
    
41. SHIBATA M, Otsuka Y, Hagiya H, Koyama T, et al
    Changes in the place of death before and during the COVID-19 pandemic in Japan.
    PLoS One. 2024;19:e0299700.
    PubMed         Abstract available
    
    
42. WANG Y, Liu Y, Liu G, Sun X, et al
    Analysis of data from two influenza surveillance hospitals in Zhejiang province, China, for the period 2018-2022.
    PLoS One. 2024;19:e0299488.
    PubMed         Abstract available
    
    
43. 
    Retraction: Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus.
    PLoS One. 2024;19:e0300096.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

44. DELGADO S, Somovilla P, Ferrer-Orta C, Martinez-Gonzalez B, et al
    Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.
    Proc Natl Acad Sci U S A. 2024;121:e2317851121.
    PubMed         Abstract available
    
    
45. LIAO Z, Wang C, Tang X, Yang M, et al
    Human transferrin receptor can mediate SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2024;121:e2317026121.
    PubMed         Abstract available
    
    
46. CHANG S, Shin KS, Park B, Park S, et al
    Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
    Proc Natl Acad Sci U S A. 2024;121:e2313681121.
    PubMed         Abstract available
    
    

    
    Vaccine

47. YANG XY, Liu T, Jiang SC, Zhang ZW, et al
    Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells.
    Vaccine. 2024;42:1259-1267.
    PubMed         Abstract available
    
    
48. MURPHY C, Kwan MYW, Chan ELY, Wong JSC, et al
    Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023.
    Vaccine. 2024 Feb 22:S0264-410X(24)00215-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
49. NEWALL AT, Nazareno AL, Muscatello DJ, Boettiger D, et al
    The association between influenza vaccination uptake and influenza and pneumonia-associated deaths in the United States.
    Vaccine. 2024 Feb 24:S0264-410X(24)00113-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
50. KRISTINSDOTTIR I, Haraldsson A, Thors V
    Influenza vaccination in pregnant women in Iceland 2010-2020 and the burden of influenza in pregnant women and their infants.
    Vaccine. 2024 Feb 26:S0264-410X(24)00205-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
51. YADEGARYNIA D, Keyvanfar A, Keyvani H, Tehrani S, et al
    Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.
    Vaccine. 2024 Feb 29:S0264-410X(24)00249-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
52. GUO J, Chen X, Guo Y, Liu M, et al
    Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies.
    Vaccine. 2024 Feb 28:S0264-410X(24)00218-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
53. CHERRY N, Adisesh A, Burstyn I, Charlton C, et al
    Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study.
    Vaccine. 2024;42:1168-1178.
    PubMed         Abstract available
    
    

    
    Virology

54. HUANG Y, Zhang P, Han S, Hu B, et al
    Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
    Virology. 2024;593:110031.
    PubMed         Abstract available
    
    

    
    Virus Res

55. ESSAIDI-LAZIOSI M, Perez-Rodriguez FJ, Alvarez C, Sattonnet-Roche P, et al
    Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Virus Res. 2024;339:199255.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.